Hims/Hers vs. Mochi Health GLP-1 comparison: a direct digital membership model on one side and a medication-plus-care model on the other. Original visual created for GLP-1 Reviews.
Last updated: September 4, 2026
Article type: Comparison
Primary keyword: Hims/Hers vs. Mochi Health GLP-1
Suggested canonical slug: hims-hers-vs-mochi-health-glp-1-2026-flat-rate-brand-name-access
Meta description: Hims/Hers vs. Mochi Health in 2026: compare GLP-1 pricing, brand-name access, compounded options, support, labs, and patient flow.
Hims/Hers and Mochi Health are built around different buying decisions. Hims/Hers emphasizes direct-to-consumer access, a recognizable national telehealth platform, and access to both brand-name and compounded GLP-1 options. Mochi Health emphasizes dedicated weight-management care, dietitian access, and a membership-plus-medication structure that is easier to model for many self-pay patients.
The better fit depends on what matters most to you: a broader brand-name medication pathway and app-based convenience, or a more specialized weight-management program with published compounded medication pricing and nutrition support.
As of September 4, 2026, the most important cost distinction is straightforward:
- Hims/Hers lists a $39 first-month membership, followed by $149 per month, with medication billed separately.
- Mochi Health lists a $79 monthly membership on its official site, with medication charges separate from membership. Its official medication page now shows compounded semaglutide starting at $60 per month and compounded tirzepatide starting at $90 per month, while its FAQ and GLP-1 Reviews provider profile continue to display older flat-rate figures of $99 for compounded semaglutide and $199 for compounded tirzepatide.
That pricing difference makes verification especially important. Neither provider’s introductory or starting price should automatically be treated as your final monthly cost.
Quick comparison: Hims/Hers vs. Mochi Health
| Category | Hims/Hers | Mochi Health |
|---|---|---|
| Care model | Direct-to-consumer telehealth membership | Dedicated weight-management telehealth program |
| Published membership price | $39 first month, then $149/month | $79/month; promotional terms may vary |
| Medication billing | Medication billed separately from membership | Medication billed separately from membership |
| Brand-name options | Ozempic, Wegovy, Zepbound, and other options listed on its provider profile | Wegovy and Zepbound listed on its provider profile; current availability varies |
| Compounded options | Compounded semaglutide listed on provider profile | Compounded semaglutide and tirzepatide |
| Current official starting prices | Brand-name GLP-1 cash-pay pricing starts at $149/month for some options, according to company materials | Compounded semaglutide starts at $60/month and compounded tirzepatide at $90/month on the official medication page |
| Older flat-rate figures still displayed | Not applicable | $99 semaglutide and $199 tirzepatide in the FAQ and provider profile |
| Labs included | Not included in the standard membership, according to the provider review | Not included in the standard membership, according to the provider review |
| Dietitian access | Not included in the standard membership | Included in the provider profile and official program materials |
| Prescriber model | Licensed telehealth clinicians | Licensed providers, including weight-management and bariatric-focused clinicians |
| Geographic availability | Available in most states; verify eligibility | Official FAQ states nationwide access; medication availability varies by state |
| GLP-1 Reviews designation | 4.0/5, Strong Choice | 4.8/5, Top Tier |
| Best-fit scenario | Patients prioritizing app access and brand-name flexibility | Patients prioritizing specialized weight-management support and transparent compounded pricing |
Pricing retrieval date: September 4, 2026. Prices and medication availability can change.
How GLP-1 Reviews evaluates the two providers
GLP-1 Reviews does not use a separate score for this comparison. Hims/Hers and Mochi Health are evaluated under the published GLP-1 Reviews provider scoring methodology, which weights medication authenticity, clinical quality, trust and transparency, reputation, access, support, value, and consumer protections.
The published methodology uses this formula:
Score = 0.22(Authenticity) + 0.18(Clinical) + 0.16(Trust) + 0.12(Reputation) + 0.10(Access) + 0.09(Support) + 0.08(Value) + 0.05(Protection)
Scores are calculated on a 1.0-to-5.0 scale and translated into tier labels.
- Hims/Hers is rated 4.0/5 and classified as Strong Choice.
- Mochi Health is rated 4.8/5 and classified as Top Tier.
These designations are not an overall verdict for every patient. They summarize provider attributes under the site’s methodology. A patient who wants brand-name medication may value different features from a patient who wants the lowest predictable self-pay cost or ongoing dietitian support.
Hims/Hers pricing: $39 first month, then $149 membership plus medication
Hims/Hers uses a two-part pricing structure for weight-loss care:
- A membership fee for access to the platform and care team.
- A separate medication charge based on the prescription and fulfillment route.
The company’s official weight-loss materials state that the membership costs $39 for the first month and then $149 per month afterward. The membership fee does not include medication.
The company’s official materials also state that certain FDA-approved Novo Nordisk GLP-1 medications are available at cash-pay prices starting at $149 per month. The exact price depends on the medication, formulation, dose, eligibility, and current program terms. The Hims/Hers official weight-loss page should be checked before enrollment because medication prices and availability can change.
A simplified Hims/Hers budget looks like this:
| Cost component | Published amount |
|---|---|
| First-month membership | $39 |
| Ongoing membership | $149/month |
| Medication | Billed separately |
| Laboratory testing | Not included in standard membership |
| Dietitian access | Not included in standard membership |
| Insurance orientation | Primarily self-pay in the provider profile |
The first-month $39 price is therefore not an all-in GLP-1 treatment price. It is the introductory membership charge. A patient who sees “starting at $149” for a medication should add the membership fee to estimate the monthly cost.
What Hims/Hers offers
The Hims/Hers provider profile lists a combination of brand-name and compounded options, including:
- Semaglutide products, including Wegovy and compounded semaglutide
- Ozempic
- Zepbound
- Generic liraglutide
Medication availability is not guaranteed simply because a product appears in a provider’s formulary. The prescribing clinician must determine whether a medication is appropriate, and state restrictions, pharmacy supply, and current company policies can affect fulfillment.
Hims/Hers also announced a 2026 partnership involving Novo Nordisk’s FDA-approved GLP-1 products. The company says the arrangement is intended to improve access to brand-name options through its platform. That can matter to patients who prefer manufacturer-produced medication rather than a compounded formulation.
What Hims/Hers does not include
The Hims/Hers provider review identifies several exclusions from the standard membership:
- Lab testing is not included.
- Dedicated dietitian access is not included.
- Medication is billed separately.
- State availability is not uniform across all 50 states.
- Compounded medication testing documentation is not fully established on the provider profile.
This does not mean patients cannot obtain lab work or nutrition support. It means they may need to coordinate those services through a primary-care clinician, an independent laboratory, or another professional.
Mochi Health pricing: membership plus compounded or brand-name medication
Mochi Health also separates membership from medication charges. Its official website currently displays a $79 per month membership, with a promotional first month listed at $39 under specific terms.
The official medication page currently shows:
- Compounded semaglutide starting at $60 per month
- Compounded tirzepatide starting at $90 per month
- Compounded semaglutide pills starting at $62 per month
- Brand-name Zepbound starting at $299 per month
However, the official Mochi FAQ continues to display an older flat-rate schedule:
- Compounded semaglutide: $99 per month for all listed doses
- Compounded tirzepatide: $199 per month for all listed doses
The Mochi Health official medication page and Mochi Health FAQ should therefore be read together. They indicate that Mochi is changing or expanding its medication pricing structure, with the medication page showing lower “starting at” figures and the FAQ retaining older flat-rate language.
The provider profile on GLP-1 Reviews, retrieved for this comparison, displays the $79 membership plus $99 semaglutide or $199 tirzepatide figures. That makes the following planning estimates useful, but not guaranteed:
| Mochi treatment path | Membership | Medication | Planning total |
|---|---|---|---|
| Compounded semaglutide | $79 | $99 | $178/month |
| Compounded tirzepatide | $79 | $199 | $278/month |
| Current official starting semaglutide price | $79 | From $60 | From $139/month |
| Current official starting tirzepatide price | $79 | From $90 | From $169/month |
| Brand-name Zepbound | $79 | From $299 | From $378/month |
The lower “starting at” prices may apply to specific doses or current pricing tiers. Patients should not assume that the lowest advertised medication price remains the same as the dose increases.
What Mochi Health includes
Mochi’s provider profile and official program materials identify the following features:
- Live provider visits
- Ongoing care-team messaging
- Dietitian access
- Bariatric or obesity-focused provider access
- Medication options that include compounded and brand-name pathways
- Nationwide telehealth access
- Support with insurance questions and prior authorization processes
Mochi’s official FAQ states that patients can receive provider access, care coaching, messaging, and ongoing support through the membership. It also states that diagnostic services and medications are not included in the membership subscription.
Mochi’s flat-rate pricing question
Mochi has historically been associated with flat-rate compounded medication pricing because the FAQ listed the same medication charge across a range of doses. The current medication page complicates that picture by showing “starting at” prices and multiple dose tiers.
For consumers, the practical question is not whether Mochi uses the phrase “flat rate.” It is whether the price you are quoted stays stable when:
- Your dose increases
- You move from an introductory plan to a regular plan
- You switch from compounded to brand-name medication
- Your state requires a different pharmacy
- Shipping or diagnostic services are added
- You choose a longer or shorter membership term
Ask for the price of your expected dose before paying.
Tirzepatide versus semaglutide pricing
Many patients compare providers by comparing the price of tirzepatide (Mounjaro, Zepbound) with semaglutide (Ozempic, Wegovy). The molecules are different, and so are their brand-name prices, clinical indications, dosing schedules, and availability.
Hims/Hers gives patients access to both medication categories through a broader menu, but the final cash price depends on the individual product and prescription. Mochi publishes more detailed compounded medication prices, although the current official page and FAQ do not show a single consistent schedule.
A practical price comparison should separate four questions:
- Is the medication brand-name or compounded?
- Is the price for medication only or medication plus membership?
- Does the price change as the dose increases?
- Does the price apply to your state and current pharmacy route?
Comparing a $199 compounded medication price with a $299 brand-name medication price is not an apples-to-apples comparison if one figure excludes membership or reflects a different dose.
Brand-name access: Hims/Hers has the clearer direct-to-consumer emphasis
Hims/Hers may be a closer fit for patients who specifically want to discuss FDA-approved brand-name options through a nationally recognized consumer telehealth platform.
The provider profile lists:
- Ozempic
- Wegovy
- Zepbound
- Compounded semaglutide
- Generic liraglutide
The company’s 2026 Novo Nordisk partnership also makes brand-name access a prominent part of its current positioning. Patients who want brand-name semaglutide should ask whether the prescription will be fulfilled as Wegovy, Ozempic, or another medication, because the FDA-approved indication and insurance rules may differ.
Mochi also lists brand-name options, including Wegovy and Zepbound. Its primary price-focused appeal, however, has historically been the compounded medication pathway.
Best for patients who want brand-name medication
Hims/Hers may be the closer fit for patients who:
- Prefer brand-name medication
- Want to compare multiple medication pathways through one consumer platform
- Value app-based communication
- Are comfortable paying a separate membership and medication charge
- Want a recognizable national telehealth brand
Mochi Health may be the closer fit for patients who:
- Want to compare brand-name and compounded options with a weight-management team
- Value dietitian access
- Want a live provider visit
- Are comfortable verifying dose-specific pricing
- Prefer a platform built primarily around obesity and metabolic care
Neither provider can guarantee a particular prescription. Medication selection remains a clinical decision.
Compounded medication: what patients should verify
Compounded semaglutide and compounded tirzepatide are not FDA-approved formulations. The FDA states that compounded drugs are not reviewed before marketing for safety, effectiveness, or quality in the same way FDA-approved medications are reviewed. The agency’s consumer information on unapproved GLP-1 drugs explains this distinction.
A Certificate of Analysis can provide testing information, but it does not turn a compounded medication into an FDA-approved product or establish that it is therapeutically equivalent to Wegovy, Ozempic, Zepbound, or Mounjaro.
Before choosing a compounded option, ask:
- Which pharmacy will dispense the medication?
- Is the pharmacy licensed in your state?
- What does the label say about concentration and dosing?
- Is a Certificate of Analysis available?
- What happens if the pharmacy cannot fill the prescription?
- How will the provider handle a dosing error?
- Is shipping included?
- What are the storage requirements?
- What is the refund policy after shipment?
Hims/Hers lists compounded options, but the provider profile states that third-party testing documentation is not fully established.
Brand-name versus compounded GLP-1 access: patients should confirm the formulation, pharmacy, documentation, and regulatory pathway before enrolling.
Clinical support and patient flow
Hims/Hers patient flow
Hims/Hers uses a digital-first intake process. The provider’s published intake walkthrough identifies a multi-stage questionnaire that covers:
- Weight-loss goals
- Height and weight
- State eligibility
- Eating-disorder risks
- Mental-health questions
- Medical history
- Family history
- Current medications
- Allergies
- Substance-use questions
- Blood-pressure and heart-rate information
The flow is designed to be completed online before clinician review. That can make onboarding convenient for busy professionals and parents who prefer asynchronous care.
The tradeoff is that the standard membership does not include laboratory testing or dedicated dietitian access. Patients who want those services should plan how they will obtain them separately.
Mochi Health patient flow
Mochi’s published intake walkthrough is shorter and is designed to lead into a live provider visit. The intake includes:
- Account creation
- Identity information
- State of residence
- Treatment interests
- Recent weight-loss medication use
- Medical conditions
- Height and weight
- BMI calculation
- Membership selection
- Checkout
- Scheduling for provider care
Mochi’s model relies more heavily on the live clinical appointment for deeper medical screening. This may be attractive to patients who would rather explain their history to a clinician than complete a long questionnaire.
The limitation is that the patient may pay for or select a membership before the full clinical assessment is complete. Read the cancellation and refund terms before submitting payment.
Labs, dietitian support, and ongoing care
Labs are one of the clearest differences in what the two memberships include.
Hims/Hers
The Hims/Hers provider review states that routine lab testing is not included in the standard membership. A clinician may still request laboratory data depending on a patient’s history, medications, symptoms, or treatment plan.
Patients may need to use:
- A primary-care physician
- Quest Diagnostics
- Labcorp
- Another licensed laboratory
- Existing recent laboratory results, if accepted by the clinician
Mochi Health
Mochi’s provider review also states that lab testing is not included in the standard membership. Its care model instead emphasizes provider visits, dietitian access, bariatric specialists, and medication management.
This means Mochi may offer more nutrition support than Hims/Hers, but neither platform should be assumed to include a complete laboratory-monitoring package.
Best for patients who want dietitian access
Mochi Health is the more direct match because dietitian access is listed as part of its care model.
Best for patients who already have outside clinical support
Hims/Hers may be workable for patients who already have a primary-care clinician, recent lab work, or an independent dietitian. The platform’s value is more concentrated in app-based access, prescription management, and medication flexibility.
Side effects, duration, and when to seek care
Both semaglutide and tirzepatide can cause gastrointestinal side effects. Common symptoms include:
- Nausea
- Vomiting
- Diarrhea
- Constipation
- Abdominal discomfort
- Reduced appetite
Symptoms are often more noticeable after starting treatment or increasing the dose. Many patients experience improvement as the body adjusts, but duration and severity vary.
The FDA-approved Wegovy prescribing information and Zepbound prescribing information describe important warnings involving severe gastrointestinal reactions, pancreatitis, gallbladder disease, kidney injury, and other risks.
Contact your prescribing clinician if side effects are persistent, worsening, or interfere with eating, drinking, sleep, work, or daily activities.
Seek urgent medical care for:
- Severe or persistent abdominal pain
- Pain that radiates to the back
- Repeated vomiting
- Inability to keep fluids down
- Yellowing of the skin or eyes
- Fever with upper-right abdominal pain
- Facial or throat swelling
- Trouble breathing
- Signs of severe dehydration
Do not increase, decrease, restart, or combine GLP-1 medications without guidance from a licensed prescriber.
Best for specific patient scenarios
Best for brand-name GLP-1 access: Hims/Hers
Hims/Hers has the clearer direct-to-consumer emphasis on brand-name options. Its provider profile lists Ozempic, Wegovy, and Zepbound, and the company’s Novo Nordisk partnership makes brand-name access a central part of its current positioning.
Best for compounded medication price transparency: Mochi Health
Mochi Health provides more detailed public pricing for compounded semaglutide and compounded tirzepatide. However, the official page and FAQ currently show different pricing structures, so patients should confirm the price for their exact dose.
Best for dietitian access: Mochi Health
Mochi’s provider profile and official materials identify dietitian access as part of its program. That may matter to first-time GLP-1 users who want nutrition support alongside medication management.
Best for app-based convenience: Hims/Hers
Hims/Hers offers a large-scale digital platform with app-based messaging, prescription management, progress tracking, and a familiar consumer-health interface.
Best for patients who want a live weight-management visit: Mochi Health
Mochi’s onboarding leads to a live provider visit and a dedicated weight-management pathway. That may be preferable to patients who want a real-time conversation before deciding on medication.
Best for patients who want to use external primary-care support: Hims/Hers
Patients who already have a primary-care physician, recent lab work, or outside nutrition support may find Hims/Hers easier to layer onto their existing healthcare arrangements.
Refund policies and cancellation terms
Refund and cancellation policies can materially affect the total cost of a GLP-1 program.
Before enrolling with Hims/Hers, confirm:
- When the membership renews
- How cancellation works
- Whether canceling membership ends medication access
- Whether medication orders can be canceled after processing
- Whether shipped medication is refundable
- Whether the first-month promotional fee has different terms
Before enrolling with Mochi, confirm:
- Whether the $39 price is promotional or a one-month plan tier
- Whether a longer membership term changes the effective monthly cost
- When the membership renews
- Whether medication is refundable after shipment
- What happens if you are found ineligible after payment
- Whether changing medication changes your monthly charge
Do not rely on a landing-page price alone. Read the checkout terms and save a copy of the receipt.
Hims/Hers vs. Mochi Health pricing comparison: the two providers use separate membership and medication charges, but the published medication schedules differ.
What to verify before choosing either provider
Use this checklist before paying:
Confirm the complete monthly cost
Ask for the total expected cost, including:
- Membership
- Medication
- Shipping
- Follow-up visits
- Labs
- Supplies
- Dose changes
- Insurance-related charges
Confirm the medication formulation
Ask whether the prescription will be:
- FDA-approved brand-name medication
- Compounded medication
- Oral medication
- Injectable medication
- A specific product subject to state restrictions
Confirm your state’s availability
Telehealth prescribing and pharmacy fulfillment rules vary. A medication listed on a national website may not be available in your state.
Confirm the clinical follow-up schedule
Ask how often you will meet with a clinician, how dose changes are handled, and how quickly you can receive help with side effects.
Confirm pharmacy details
Ask which pharmacy dispenses your prescription and how the medication will be shipped and stored.
Confirm what happens if treatment changes
Ask whether you can switch from semaglutide to tirzepatide, move from compounded to brand-name medication, pause treatment, or transfer care.
FAQ: Hims/Hers vs. Mochi Health
Is Hims/Hers or Mochi Health better for GLP-1 treatment in 2026?
Neither provider is universally better for every patient. Hims/Hers may fit patients who prioritize brand-name medication access, app-based care, and a broad direct-to-consumer platform. Mochi Health may fit patients who prioritize dedicated weight-management care, dietitian access, and published compounded medication pricing. GLP-1 Reviews rates Hims/Hers Strong Choice and Mochi Health Top Tier under its published methodology, but the tier labels do not replace a patient-specific clinical decision.
How much does Hims/Hers cost for GLP-1 treatment?
Hims/Hers lists a $39 membership fee for the first month and $149 per month afterward. Medication is billed separately. The company’s official materials state that some FDA-approved GLP-1 options are available at cash-pay prices starting at $149 per month, but the final cost depends on the medication, dose, formulation, eligibility, and current availability. The membership price should not be treated as an all-in medication price.
How much does Mochi Health cost for semaglutide and tirzepatide?
Mochi Health’s official website currently lists a $79 monthly membership. Its medication page shows compounded semaglutide starting at $60 per month and compounded tirzepatide starting at $90 per month. The official FAQ and GLP-1 Reviews provider profile continue to display older flat-rate prices of $99 for semaglutide and $199 for tirzepatide. Patients should confirm the exact charge for their dose and state before enrolling.
Does Mochi Health offer brand-name GLP-1 medications?
Yes. Mochi Health lists brand-name options including Wegovy and Zepbound, subject to clinical eligibility, insurance rules, state availability, and pharmacy fulfillment. Its strongest public pricing emphasis remains compounded semaglutide and compounded tirzepatide. Ask the clinician and pharmacy to confirm whether the prescription is brand-name or compounded before paying.
Does Hims/Hers include lab testing?
No. The Hims/Hers provider review states that lab testing is not included in the standard membership. A clinician may request labs depending on your medical history and treatment plan, but you may need to arrange and pay for testing through your primary-care clinician or an independent laboratory.
Does Mochi Health include a dietitian?
Yes. Dietitian access is listed as part of Mochi Health’s program and provider profile. The membership does not automatically include diagnostic lab testing, so patients should confirm which laboratory services are recommended and whether those costs are billed separately.
Are compounded semaglutide and tirzepatide FDA-approved?
No. Compounded semaglutide and compounded tirzepatide are not FDA-approved formulations. The FDA does not review compounded drugs for safety, effectiveness, or quality before marketing in the same way it reviews approved medications. A Certificate of Analysis may provide testing documentation, but it does not make a compounded medication FDA-approved or therapeutically equivalent to Wegovy, Ozempic, Zepbound, or Mounjaro.
Conclusion: compare the care model before comparing the headline price
Hims/Hers and Mochi Health represent two different approaches to GLP-1 access.
Hims/Hers is built around a recognizable direct-to-consumer platform, app-based support, and access to both brand-name and compounded options. Its membership starts at $39 for the first month and then increases to $149 per month, with medication billed separately. It may be a closer fit for patients who prioritize brand-name access, digital convenience, and a broad medication menu.
Mochi Health is built around dedicated weight-management care, live provider visits, dietitian access, bariatric-focused support, and a membership-plus-medication model. Its official medication page currently shows lower starting prices than the older flat-rate figures still displayed in its FAQ and provider profile. That makes Mochi potentially attractive to self-pay consumers, but it also means patients should confirm the current price for their exact dose before enrolling.
Use Hims/Hers when brand-name medication access and a consumer-focused app experience are central to your decision. Consider Mochi Health when dietitian support, live weight-management care, and transparent compounded medication pricing are more important.
In either case, compare the full monthly cost, verify the formulation, review the pharmacy details, and confirm how follow-up care works before paying.
This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting any medication.
Corrected 8 October 2026. An earlier version of this article said Mochi Health provides certificate of analysis (CoA) documentation. That was our error, copied from our earlier Mochi review: its site does not offer one.
Corrected 9 October 2026. We removed 2 generated images from this article. Generated images on this site no longer show certifications, organisations, products, prices or figures unless the specific claim has been checked.
Keep exploring our GLP-1 resources:
